SAN FRANCISCO, CA–(Marketwired – March 01, 2016) - Medrio, Inc., a leading Software as a Service (SaaS) provider of electronic data capture (EDC), will be hosting its annual user conference, mSquared, at the Loews Regency hotel in San Francisco, CA on March 21st, 22nd, and 23rd. This year’s conference, named Medrio Rocks, will have a rock and roll theme and will feature a welcome reception, rock and dance party, and two full days of presentations, workshops, panels, new product demos, and plenty of opportunities to meet and mingle with Medrio staff and users. The event is open only to Medrio customers, users, partners, and consultants.
Medrio began holding the annual mSquared user conference to better connect with customers by providing them with top-notch training and Medrio resources. Over the course of two days, Medrio users will gain powerful insights from Medrio’s expert staff through interactive workshops, new release highlights, and presentations from fellow users. Scott Weidley, Vice President of Sales, Marketing, and Customer Success, explains Medrio’s customer-centric approach: “At Medrio, we believe that understanding what our customers want and need is incredibly important. Having our users in one place over two days allows us to connect on a more personal level, provide them with Medrio resources, and learn from their user experiences.”
If you are currently a Medrio user and would like to attend mSquared, please contact Medrio’s Marketing team at firstname.lastname@example.org. If you would like to learn more about Medrio’s CloudEDC™ software solution, please contact our Sales team for a demo by filling out this form.
Medrio offers an integrated eClinical software platform with a fully hosted EDC system. Our revolutionary CloudEDC™ technology features an easy to use drag-and-drop interface, allowing study managers to build their studies in days instead of months without requiring any programming. Medrio’s new mobile suite, mSource, supports both event-based and subject-based workflows, offline data entry, and Patient Reported Outcomes (PRO). Although Medrio has extensive experience in all study phases, with over 500 Phase I trials to date, our m1 application leads the way in early phase and Phase I trials. Medrio costs up to 75% less than traditional EDC solutions.
For more information please visit: www.medrio.com.